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Periapical lesions are inﬂammatory conditions of tooth periapical tissues, triggered by dental pulp infection and characterized by
exudation of immune cells to the aﬀected tissues and production of inﬂammatory mediators such as cytokines. The inﬂammatory
periapical reaction is mainly driven by Th1, Th2, and Th17 responses, and such polarization may modulate progression of the
disease and expression of bone proresorptive cytokines. IL-12 is a potent inducer of IFN-γ production, which stimulates Th1
eﬀector cells. Many evidences have shown a positive correlation between the bone resorptive cytokine IL-1β and the production
of IL-12 and IFN-γ. Furthermore, IL-12 may have a potential role in the release of bone resorptive mediators and blockade of Th2
cytokines, aﬀecting the progression of periapical bone loss. Nevertheless, IL-12 and IFN-γ have also been described as suppressors
of osteoclast diﬀerentiation and activation, favoring bone maintenance. This paper focuses on the controversial roles of IL-12 in
periapical lesions.
1.Introduction
Interleukin 12 (IL-12) is an important regulatory cytokine
that has a pivotal function in the initiation and regulation of
cellular immune responses. It can regulate the diﬀerentiation
of naive T cells, which are crucial in determining resistance
and the type of response that will be elicited against a partic-
ularpathogen[1].IL-12ismainlyproducedbymacrophages,
monocytes, dendritic and B cells in response to bacterial
products and intracellular parasites. It is also primarily
responsible for the subsequent production of interferon-
gamma (IFN-γ)a n dt u m o rn e c r o s i sf a c t o r - a l p h a( T N F - α)
from NK cells and T helper cells. IL-12-induced IFN-γ
secretion enhances phagocytosis, production of nitric oxide
(NO), and oxidative burst, resulting in increased destruction
of pathogens [2]. IL-12 also has been well characterized as a
suppressor of Th2 cytokines, such as IL-4 and IL-10 [3]. For
its roles in immune responses, IL-12 has been implicated in
the pathogenesis of several diseases, including inﬂammatory
diseases such as rheumatoid arthritis [4], psoriasis [5], and
Crohn’s disease [6] and oral conditions such as periodontitis
[7]. The aim of this paper is to discuss the mechanisms
associated to the IL-12-related immune response in tooth
periapical lesions.2 Clinical and Developmental Immunology
2.PeriapicalLesions:Concepts
and Nomenclature
Dental pulp is protected from microorganisms of the oral
cavity by enamel and dentin. The exposure of dental pulp
to microorganisms and their products, as a consequence
of dental caries, fractures, or operative procedures, triggers
a local inﬂammatory response. The progression of such
infection and inﬂammation results in necrosis of the pulp
and consequent involvement of periapical tissues, generating
a periapical lesion [8, 9]. In periapical lesions, an initial
short acute inﬂammatory response of varied intensity is
accompanied by pain, tooth elevation, and tenderness to
percussion. Tissue changes are characterized by hyperemia
and neutrophil recruitment, usually limited to the periodon-
tal ligament. With the continuous presence of irritants at
periapex, the acute response shifts to the formation of a
granulomatous tissue with chronic inﬂammatory cells and
ﬁbroblasts: the apical granuloma [8, 9]. Such condition is
asymptomatic and accompanied by a radiolucent area for-
mation as result of periapical bone resorption. A granuloma
can remain latent or be converted to inﬂammatory cysts by
poorly understood mechanisms. Cysts are diagnosed as pre-
senting fully developed cavities lined by stratiﬁed squamous
epithelium with variable thickness and a ﬁbrous capsule [8].
These pathological changes in periapical tissues are the
clinical consequence of the host defensive reaction against
bacterial products that egress through apical foramen from
infected dental pulp [8, 10, 11]. This response is charac-
terized by the persistent migration of polymorphonuclear
leukocytes, monocytes, lymphocytes, plasma, and mast cells
totheinfectedsites,anditlargelypreventsmicrobialinvasion
into the periapical tissues [8, 12, 13]. Such immunological
response seems to be similar to other reactions to bacterial
infections in the body, except for the resorption of the
periapical bone [14]. In this regard, although the commit-
ment of immune cells and the consequent production of
inﬂammatory mediators protect the host from pathogen
invasion, it may paradoxically account for much of the
periapical bone resorption [8, 15].
3. Involvement of T Cells in PeriapicalLesions
Periapical lesions are marked by the expression of cell surface
adhesion molecules, production of chemotactic factors [16,
17], and release of cytokines, including the bone prore-
sorptive interleukin (IL)-1, IL-6, and tumor necrosis factor
(TNF)-α [14, 18–22]. Such response is primarily regulated
by a network of other T-cell-derived cytokines, including
members of the IL-12 family [18, 23, 24].
T-helper (Th) cells are the primary cell type responsible
forregulatingcytokine-mediatedimmuneresponses,andthe
diﬀerentiation of na¨ ıve CD4+ Th cells into eﬀectors T cells is
critical[25].CD4+ eﬀectorTcellscanbedividedintodistinct
lineages such as Th1, Th2, Th17, and regulatory (Treg)
cells. In this context, members of the IL-12 cytokine family
have abilities to help diﬀerentiation and/or maintenance of
Th1 cells, and their production is one of the key events
in the diﬀerentiation of T cell populations. IL-12 and its
family members, IL-23 and IL-27, also act as cofactors to
enhance T-cell proliferation [3, 26–28]. IL-12 is a potent
inducer of interferon (IFN)-γ production, which stimulates
Th1 eﬀector cells. Chronologically diﬀerential roles of IL-12,
IL-23, and IL-27 have been proposed for Th1 diﬀerentiation:
ﬁrst, IL-27 commits na¨ ıve CD4+ Tc e l l st od i ﬀerentiate into
Th1 cells by activating IL-12 receptor 2, and then IL-12 acts
on committed eﬀector Th1 cells stimulating IFN-γ produc-
tion, which is followed by IL-23-mediated proliferation of
memory Th1 cells [29]. Also, IL-23 produced by dendritic
cells and na¨ ıve CD4+ T cells induces the diﬀerentiation of
Th17 cells. IL-23 production is mediated by the recognition
of speciﬁc structural motifs of various pathogens by Toll-
like receptors (TLRs) 2 and 4. The TLR2 and TLR4 agonists
(peptidoglycan and LPS, resp.) readily induce IL-12/23p40
expression and, consequently, IL-23 production, favoring
Th17 diﬀerentiation [30, 31]. Then, Th17-diﬀerentiated cells
are able to release IL-17, also inducing IFN-γ production
[26, 32].
A common feature of periapical lesions, independent
of their underlying cause, is the persistent exudation of
a large number of immunocompetent cells, with T cells
beingpredominantcellularcomponentsinhumanperiapical
pathologies [33–35]. It is well known that the inﬂammatory
periapical reaction is driven by Th1, Th2, Th17, and
Treg responses, and such polarization may modulate the
expression of bone proresorptive cytokines [18, 32, 36].
AlthoughsomestudieshavesupportedTcellshavingaminor
role in the pathogenesis of periradicular lesions [37, 38],
large amount of evidence indicates that the progression of
such disease, with bone resorption, requires Th1 and Th17
cells, while Th2 and Treg cells are related to the chronicity of
inﬂammation [32, 36, 39].
Indeed, periapical lesions do not progress over a long
period in congenitally nu/nu T cell-deﬁcient mice, which
lack a source of T cells. In these animals, the progression
of experimentally induced periapical lesions ceased after
6 weeks of infection and was characterized by numerous
ﬁbroblasts instead of inﬂammatory cells in the aﬀected
tissues 8 weeks after pulp exposure [40].
Consistent with these ﬁndings, some studies demon-
strated that Th1 immune response is important for all
stages of periapical lesion progression, while Th2 immune
modulatory response might be related to asymptomatic
and chronic lesions [32, 36, 39]. Along with Th1 and Th2
responses, some recent evidence also implicates IL-17 as an
important cytokine responsible for the progression of apical
periodontal lesions [32, 41].
Somehow,thedevelopmentandprogressionofperiapical
lesions is dependent on T cells and, consequently, on the
mediators released by them.
4.IL-12-Related ImmuneResponses in
PeriapicalLesions
The expression of most of Th1 cytokines, including IL-2, IL-
12, and IFN-γ, has been shown to be increased in periapical
lesions after experimental pulp exposure. Although the cellClinical and Developmental Immunology 3
source of IL-12 in periapical tissues has not been deﬁned
yet, it is probable that macrophages and dendritic cells are
responsible for the secretion of such cytokine [42]a n d
that Th1 cells may respond to macrophage-derived IL-12
releasing IFN-γ and IL-2 [43]. On the other hand, the
expression of Th2-type cytokines was similarly increased in
periapical tissues, but had declined at the latest time-point,
suggesting a possible inhibition by Th1-type mediators
[18]. In fact, IL-12 also has been well characterized as
a suppressor of Th2 cytokines, such as IL-4 [3]. This
immunological interaction could support the destruction
of periapical tissues. In this regard, signiﬁcant correlations
were observed between levels of IL-1α and Th1-derived
proinﬂammatory mediators IL-2, IL-12, TNF-α,a n dI F N - γ
[18].Nevertheless,therewasalackofcorrelationbetweenIL-
1αandTh2-typeanti-inﬂammatorymediators,includingIL-
4, IL-6, and IL-10 [18]. These data point toward a potential
role of IL-12 in the release of proinﬂammatory mediators
and blockade of Th2 cytokines, which could favor the
progression of infection-induced periapical lesions. Besides
this Th1/Th2 paradigm, Th17 cells were recently described
as having a role in the IL-12-related immune response in
apical lesions. Xiong et al. [44] reported that the number
of cells expressing IL-17 increased along the postoperative
time in experimentally induced periapical lesion in rats,
and Marc ¸al et al. [41] showed that the frequency of IL-17
positive cells was signiﬁcantly higher in radicular cysts and
granulomas than in healthy human tissues. IL-17 secreted
by Th17 cells can induce IFN-γ production by diﬀerentiated
CD4+ T cells exacerbating the inﬂammatory process [32].
In addition, IL-17 is able to augment the expression of the
neutrophilchemokinesCXCL1andCXCL5,asdemonstrated
in experiments using IL-17R−/− mice, favoring the host
responseagainstperiodontopathogens[45].Despitethisnew
insight of Th17 response in the understanding of the IL-12-
related immune pathway in periapical lesions, not much of it
is known yet, and the current broad knowledge still focuses
on Th1 and Th2 responses.
Previous studies from our group pointed towards a
predominance of distinct Th cell types in human periapical
conditions being Th1 markers associated with granuloma,
while Th2 mediators augmented in cysts. However both
lesions exhibited similar expression of IL-4 and IFN-γ [16,
36]. Conversely, other investigation has found a regulatory
environment in granulomas, with high transforming growth
factor (TGF)-β and low proinﬂammatory cytokine levels. In
contrast, periapical cysts were characterized by a Th1 and
Th2 response, with increased IFN-γ,T N F - α, and IL-4 levels
which were correlated to clinical evidence of swelling and
tendernesstopercussion[46].OtherstudiessuggestthatTh1
response is predominant in apical granulation tissues, while
Th2 response is dominant in human periapical regenerating
lesions [21, 47]. On the other hand, experimental models
suggest a hierarchy of Th2 cytokines in the immunomodu-
lation of apical periodontitis, given that the absence of Th1-
type cytokines (IFN-γ and IL-12) does not interfere with
the lesion development [23, 24], whereas the deﬁciency of
Th2 cytokines, IL-6 [20]a n dI L - 1 0[ 23, 48], increases the
extension of apical lesions.
In order to determine the individual function of the
Th1-driven cytokines IL-12 and IFN-γ in the pathogenesis
of periapical bone destruction, Sasaki et al. [24]u s e da
well-established model of periapical lesion in appropriate
knockout mice. Periapical lesion was induced by inocu-
lation of a bacterial load into the root canal system of
mice’s 1st molars, and their results indicated that IL-
12−/− and IFN-γ−/− mice had similar bone resorption
in vivo, compared to wild-type mice. Infusion of recom-
binant IL-12 in infected conventional animals (in order
to detect whether a high concentration of the cytokine
could induce any alteration in bone resorption) also did
not alter periapical bone loss. Herein, an in vitro study
was performed, and they demonstrated that recombinant
IL-12 and IFN-γ failed to modulate macrophage IL-1α
production [24]. Thus, at least individually, IL-12 and
IFN-γ did not seem to have a signiﬁcant eﬀect on the
pathogenesis of periapical lesions in vivo.I ti si m p o r t a n t
to consider that the individual eﬀect of leukocytes subsets
and cytokines is usually investigated in highly controlled
systems, while in vivo the putative function of cytokines
must be estimated in the view of a complex milieu, with
presence of several other cytokines, which can modulate or
be modulated by them until the determination of a clinical
outcome.
Nevertheless, in sharp contrast, another research group
found divergent results in IFN-γ−/− mice, essentially using
a similar experimental model [23]. IFN-γ−/− animals pre-
sented an increased periapical bone loss in relation to wild-
type animals, but a reduced neutrophil number associated
to a relative increase in the number of mononuclear cells
at the periapical region. Bacterial quantiﬁcation inside the
root canal system and the number of osteoclasts in the
periapical bone were similar to wild-type mice. These results
suggest a role for IFN-γ as a suppressor of periapical lesion
bone destruction [23]. Some methodological diﬀerences
could explain these divergent results, such as the quanti-
tative method used to analyze bone loss (microcomputed
tomography versus histological analysis) and the diﬀerent
bacterial strains used to induce pulp infection, which could
be responsible for distinct patterns of bone resorption
[23, 24]. In fact, the presence of speciﬁc pathogens is
able to interfere with cytokine milieu, turning in vivo
models scenario with multiple bacterial species even more
complex to be evaluated, but possibly more close to
mimic human lesions. Despite the controversy, both studies
suggested a possible functional redundancy in pro- and
anti-inﬂammatory pathways related to periapical lesions.
Although the IL-12-IFN-γ pathway is immunologically
described as a predominantly Th1 proinﬂammatory and
bone-destructive-inducing system, it has also been described
as a suppressor of osteoclast diﬀerentiation and activation
[49, 50].
The alteration in the balance of these opposing
processes—proinﬂammatory signals to prevent infection
versus osteoclast inhibitory activity—could explain the
apparent lack of eﬀect of IL-12 in the control of pulp
infection and periapical lesion development.4 Clinical and Developmental Immunology
5. Effects of IL-12 on Periapical
BoneResorption
Periapical bone resorption is caused by the imbalance
between osteoblast and osteoclast activity. Bone formation
can be driven by factors such as bone morphogenetic
proteins, cytokines, and growth factors, which induce the
diﬀerentiation of precursor cells into osteoblast phenotype
[51–53]. Once diﬀerentiated, the osteoblasts produce several
proteins which will compose newly formed bone [54]a n d
then undergo diﬀerentiation under osteocyte phenotype
[55]. While no data is available in the literature concerning
the expression of bone formation markers speciﬁcally in
periapical lesions, recent studies demonstrate that inﬂam-
matory cytokines (described to be upregulated by Th1
responses) interfere in coupled bone formation (the process
of equivalent bone formation of the amount of bone
resorbed, which takes place under homeostatic conditions)
[56, 57] suggesting that this phenomenon may also account
for bone loss in periapical lesions. On the other hand,
diﬀerentiation and activation of osteoclasts, and consequent
bone resorption, is driven by RANK (receptor activator
of nuclear factor-κB), its ligand RANKL, and its soluble
counterpart OPG (osteoprotegerin) [58]. RANKL binding to
the receptor RANK, present on the surface of preosteoclasts,
drives their maturation and activation, while OPG acts
as a decoy receptor and inhibits RANK-RANKL engage-
ment [58]. Interestingly, periapical granulomas present with
heterogeneous patterns of RANKL and OPG expression,
ranging from samples with RANKL/OPG ratio similar to
that seen in sites with absent bone resorption to patterns
indicative of active bone resorption [59]. Such imbalance is
triggered by the main cytokines produced during the acute
phase of periapical lesion: RANKL, IL-1α,I L - 1 β,a n dT N F - α
[10, 11, 19, 60–63]. Many evidences have shown a positive
correlation between the bone resorptive cytokine IL-1β and
the production of IL-2, IL-12, TNF-α,a n dI F N - γ [18, 19].
Most of them are Th1 cytokines, and they are produced
during the acute phase of periapical lesions. On the other
hand, the chronic phase of disease is characterized by the
production of Th2 cytokines (IL-4, IL-6, IL-10, and IL-13)
thatreducetheboneresorptionactivity[7].Suchaﬃrmation
was demonstrated by experiments using IL-10−/− mice. The
absenceofIL-10leadstothedevelopmentoflargerperiapical
lesion compared to wild-type mice. Besides, the levels of IL-
1β and IL-12 were remarkably higher compared to wild-type
animals, indicating that IL-10 acts as a suppressor of IL-1β
and IL-12 overproduction [7, 48]. Other Th2 cytokines like
IL-4 and IL-13 can also inhibit bone resorption by reducing
the production of Th1 cytokines [19]. Paradoxically, gene
knockouts of the prototype Th1 mediator interferon (IFN)-
γ or IFN-γ-inducing cytokines IL-12 and IL-18 have no
signiﬁcant eﬀect on periapical bone destruction, suggesting
either a lack of regulatory activity or functional redundancy
in proinﬂammatory pathways [24].
It can be considered that IL-12 has dichotomic eﬀects
related to osteoclastogenesis as illustrated in Figure 1.O n e
of those is the induction of osteoclast diﬀerentiation by
enhancing the production of IL-1β and Th1 cytokines and
provoking destructive osteolysis around root apex during
the development of periapical lesion [19]. However, in vitro
studies demonstrated that IL-12 indirectly reduces RANKL-
induced osteoclast diﬀerentiation alone or in synergy with
IL-18 [64]. Moreover, it seems that T cells play an important
role in the osteoclastogenesis inhibition by IL-12 since
their absence in these cultures ablated the eﬀects of IL-
12 treatment [64]. Other group showed that IFN-γ also
suppresses RANKL-induced osteoclast diﬀerentiation and
mature osteoclast function by enhancing the IFN-γ-induced
degradation of the RANK adapter protein, TRAF6 (tumor
necrosis factor receptor-associated factor 6), which results
in strong inhibition of the RANKL-induced activation of
the transcription factors NF-κBa n dJ N K[ 50]. Interestingly,
genetic ablation of chemokine receptor CCR5, character-
istically expressed by Th1 polarized lymphocytes, results
in formation of larger periapical lesions [23], reinforcing
the potential protective role of IFN-γ in bone lytic lesions.
Therefore, we can wonder that the inhibitory eﬀects of
IL-12 in the osteoclast diﬀerentiation are at least in part
dependent on IFN-γ production by T-cells. However, the
proinﬂammatory eﬀect of IFN-γ demonstrated in vivo,
which results in the upregulation of the levels of TNF-α
and IL-1β (and consequently RANKL), seems to overcome
the direct antiosteoclastogenic eﬀect described in vitro [65,
66]. In addition, IFN-γ also stimulates osteoclast formation
and bone loss in vivo via antigen-driven T cell activation
or through the chemoattraction of RANKL+ cells [65–67].
In accordance with the potential destructive role of IL-
12-driven and IFN-γ-mediated Th1 responses in periapical
lesions, unpublished data from our research group support
this hypothesis. When periapical granulomas were catego-
rized into active or inactive based on the RANKL/OPG
expression pattern (as previously cited) [59], our results
demonstrate that the expression of both IL-12 and IFN-γ is
signiﬁcantly higher in active lesions, while Th2- and Th22-
type cytokines prevail in inactive lesions.
Moreover,althoughnodataisavailabledirectlyregarding
periapical lesions, the recently described IL-23/IL-17 axis
also might account for the divergent eﬀects of IL-12 on
boneresorption.IL-23isaheterodimericcytokineconsisting
of an IL-12p40 subunit coupled with IL-23-speciﬁc p19
subunit. It shares with IL-12 the IL-12Rβ heterodimer
in their receptors, activating many of the same signaling
molecules and transcription pathways [68, 69]. In a model
of arthritis, Th17 cells stimulated by IL-23 promote osteo-
clastogenesis through production of IL-17, which in turn
induces mesenchymal cells to release RANKL [69, 70]. IL-
23 can also stimulate osteoclast formation by direct action
on myeloid precursors (inducing RANK expression) and
indirectly on osteoblasts (upregulating RANKL expression)
[69]. A recent study showed that IL-23 dose-dependently
upregulates RANK expression in murine bone marrow
macrophages and RAW264.7 cells promoting osteoclastic
diﬀerentiation in an IL-17-independent pathway. The results
also showed that IL-23 synergizes with RANKL to drive
osteoclast formation but IL-23 by itself is not able to induce
osteoclastogenesis [71]. Nevertheless, like IL-12, IL-23 can
act synergistically with IL-18 to block osteoclastogenesis inClinical and Developmental Immunology 5
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Figure 1: Schematic drawing showing the controversial role of IL-12 on bone resorption at apical periodontal sites. The progression of
dental pulp infection triggers an inﬂammatory response in periapical tissues. Inﬂammatory cells, such as macrophages, are recruited for that
regionandreleaseproinﬂammatorymediators.OneofthosemediatorsisIL-12,whichinduces Th1cellstoproduceIFN-γ.TheIL-12-IFN-γ
pathway can induce bone resorption by production of proinﬂammatory cytokines, such as TNF-α and IL-1β, which leads to the activation
of osteoclasts. In contrast, this pathway is also involved in the degradation of the RANK adapter protein, TRAF6, which reduces RANKL-
induced osteoclast diﬀerentiation. In this context, dendritic cells and na¨ ıve CD4+ cells also produce the IL-12 family member cytokine IL-23,
which induces the diﬀerentiation of Th17 cells. These cells release IL-17, enhancing the IFN-γ production. In favor of this proinﬂammatory
environment IL-12 also may blockade Th2 cytokines, stimulating the progression of infection-induced periapical lesions. These opposing
mechanisms may explain the discrepant ﬁndings regarding IL-12 and IFN-γ in the pathogenesis of periapical lesions. IFN-γ: interferon-γ;
RANK: receptor activator of nuclear factor κB; TRAF6: tumor necrosis factor receptor-associated factor 6.
aC D 4 + T cell-dependent manner in vitro. Interestingly, IL-
23 does not seem to mediate IL-12 action, although IL-
12 can induce its expression [72]. Also, osteoclastogenesis
from bone marrow cells induced by soluble RANKL was
partially inhibited by IL-23, with reduced multinucleated cell
numbers, but this interleukin did not aﬀect the proliferation
of osteoclast progenitor cells [73]. These ﬁndings point to a
yetdivergentscenarioofthiscytokineinconditionsinvolving
bone resorption. Therefore, an approach comprising the
evaluation of multiple instead of individual cytokines would
provide a broader basis to deﬁne the cytokines role in peri-
apical lesions outcome, since it takes in account the overall
balance of cytokines with opposing or similar functions.
Also, the determination of the putative disease activity by
means of RANKL/OPG pattern overcomes the absence of
deﬁnitive clinical data concerning the actual disease activity
(i.e., active bone resorption), which certainly contribute
to the conﬂicting results regarding the role of IL-12 (and
also the other several cytokines involved) in periapical
lesions development. Finally, the growing application of
experimental models using genetically modiﬁed mice strains
allows the cause-and-eﬀect relationships, providing impor-
tant contributions to the study of the immunopathogenesis
of periapical pathologies [63, 74, 75].
6. Concluding Remarks
The development and progression of periapical lesions is
markedly dependent on the inﬂammatory reaction triggered
by pulp infection. IL-12 is related to the diﬀerentiation of
Th1 cells, and there is evidence that Th cells are directly
involved in the progression of periapical lesions and bone
resorption. Th1 cells respond to macrophage-derived IL-12
releasing IFN-γ and suppressing Th2 cytokines, favoring the6 Clinical and Developmental Immunology
infection-induced bone loss. Thus, the IL-12-IFN-γ pathway
may contribute to the progress of periapical lesions due to its
proinﬂammatory actions. Furthermore, Th17 cells diﬀeren-
tiated upon IL-23 production also seem to stimulate proin-
ﬂammatorytoothperiapicalreactionthroughIL-17-induced
IFN-γ release. Some studies showed that, individually, there
is no eﬀect of IL-12 and IFN-γ in the pathogenesis of peri-
apical lesions. The proinﬂammatory role of IL-12 in these
lesions seems to be counterbalanced by its inhibitory eﬀects
in the osteoclast diﬀerentiation, which, at least in part, is also
dependent on IFN-γ production. In conclusion, IL-12 seems
to have a dual role in the pathogenesis of periapical lesions.
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